1. Home
  2. EVGN vs ASBP Comparison

EVGN vs ASBP Comparison

Compare EVGN & ASBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Evogene Ltd

EVGN

Evogene Ltd

HOLD

Current Price

$0.84

Market Cap

7.4M

Sector

Industrials

ML Signal

HOLD

Logo Aspire Biopharma Holdings Inc.

ASBP

Aspire Biopharma Holdings Inc.

HOLD

Current Price

$0.87

Market Cap

7.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVGN
ASBP
Founded
1999
2021
Country
Israel
United States
Employees
N/A
N/A
Industry
Agricultural Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.4M
7.6M
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
EVGN
ASBP
Price
$0.84
$0.87
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$3.50
N/A
AVG Volume (30 Days)
149.8K
521.3K
Earning Date
03-05-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$73.33
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.73
$0.05
52 Week High
$2.42
$2.45

Technical Indicators

Market Signals
Indicator
EVGN
ASBP
Relative Strength Index (RSI) 43.80 44.32
Support Level $0.81 $0.20
Resistance Level $1.23 $1.61
Average True Range (ATR) 0.08 0.19
MACD 0.01 -0.01
Stochastic Oscillator 33.29 43.97

Price Performance

Historical Comparison
EVGN
ASBP

About EVGN Evogene Ltd

Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment, followed by Industry.

About ASBP Aspire Biopharma Holdings Inc.

Aspire Biopharma Holdings Inc developing next-generation absorption of medicine that will have an impact on the opioid crisis. The group engaged in the business of developing and marketing disruptive technology for novel delivery mechanisms for do-no-harm drugs. Its nanotechnology drug formulation directly targets pain and inflammation bypassing the gastrointestinal tracts.

Share on Social Networks: